Veradermics, Incorporated
MANE · Healthcare · $5.1B
$122.23+0.82%
Price
$129.7
$119.0
Jul 2, 26Oct 1, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue$0M
6/'26 vs prev quarter
Company Health
Market Cap$5.1B
Cash on Hand$820M16.2% of market cap
Free Cash Flow$-78M-1.5% of market cap
Short Float 11.7% · biweekly · settled 26.09.15
Among 464 Biotechnology peers
LowMedianHigh
PBR6.2xmedian 2.1xROE-11.4%median -54.5%Veradermics, Incorporated (NYSE:MANE) Receives Consensus Rating of “Moderate Buy” from BrokeragesSep 21
Veradermics, Incorporated (MANE) Presents at Citigroup's Biopharma Back to School Summit 2026 Prepared Remarks TranscriptSep 9
Veradermics to Present at Upcoming September Investor ConferencesSep 3
Bamco Inc. NY Purchases 169,913 Shares of Veradermics, Incorporated $MANEAug 27
Insider Selling: Veradermics (NYSE:MANE) Director Sells $10,712,000.00 in StockAug 17
Veradermics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical ProgressAug 11
